批准日期，申请提交历史，通知信，药品说明书，审评文件等信息
| 提交状态日期 | 提交号 | 审批结论 | 申请内容分类 | 审评优先级；罕用药状态 | 通知信、审评文件、说明书、包装标签 | 备注 |
|---|
| 2018/02/12 |
SUPPL-48（补充） |
Approval |
Labeling |
STANDARD
|
|
|
| 2017/10/05 |
SUPPL-45（补充） |
Approval |
Labeling |
STANDARD
|
|
|
| 2006/04/28 |
SUPPL-42（补充） |
Approval |
Labeling |
STANDARD
|
|
|
| 1996/06/07 |
SUPPL-41（补充） |
Approval |
Manufacturing (CMC) |
PRIORITY
|
|
|
| 1994/02/18 |
SUPPL-40（补充） |
Approval |
Labeling |
STANDARD
|
|
|
| 1991/04/23 |
SUPPL-39（补充） |
Approval |
Labeling |
|
|
|
| 1987/03/12 |
SUPPL-38（补充） |
Approval |
Labeling |
|
|
|
| 1986/06/04 |
SUPPL-37（补充） |
Approval |
Manufacturing (CMC) |
PRIORITY
|
|
|
| 1986/04/07 |
SUPPL-36（补充） |
Approval |
Labeling |
|
|
|
| 1984/03/01 |
SUPPL-35（补充） |
Approval |
Labeling |
|
|
|
| 1983/12/21 |
SUPPL-34（补充） |
Approval |
Labeling |
|
|
|
| 1983/04/07 |
SUPPL-33（补充） |
Approval |
Manufacturing (CMC) |
PRIORITY
|
|
|
| 1982/03/04 |
SUPPL-31（补充） |
Approval |
Labeling |
|
|
|
| 1981/01/08 |
SUPPL-29（补充） |
Approval |
Manufacturing (CMC) |
PRIORITY
|
|
|
| 1980/12/30 |
SUPPL-30（补充） |
Approval |
Manufacturing (CMC) |
PRIORITY
|
|
|
| 1979/11/05 |
SUPPL-27（补充） |
Approval |
Labeling |
|
|
|
| 1979/02/22 |
SUPPL-28（补充） |
Approval |
Labeling |
|
|
|
| 1977/02/28 |
SUPPL-26（补充） |
Approval |
Labeling |
|
|
|
| 1977/02/28 |
SUPPL-25（补充） |
Approval |
Manufacturing (CMC) |
PRIORITY
|
|
|
| 1960/09/15 |
ORIG-1（原始申请） |
Approval |
Type 4 - New Combination |
PRIORITY
|
|
|
与本品相关的专利信息（来自FDA橙皮书Orange Book）
| 关联产品号 | 专利号 | 专利过期日 | 是否物质专利 | 是否产品专利 | 专利用途代码 | 撤销请求 | 提交日期 | 专利下载 | 备注 |
|---|
| 无 |
与本品治疗等效的药品
活性成分:ATROPINE SULFATE; DIPHENOXYLATE HYDROCHLORIDE 剂型/给药途径:TABLET;ORAL 规格:0.025MG;2.5MG 治疗等效代码:AA
| 申请号 | 产品号 | 申请类型 | 商品名 | 活性成分 | 剂型/给药途径 | 规格 | 市场状态 | RLD | RS | TE Code | 产品号批准日期 | 申请人 |
|---|
| 012462 |
001 |
NDA |
LOMOTIL |
ATROPINE SULFATE; DIPHENOXYLATE HYDROCHLORIDE |
TABLET;ORAL |
0.025MG;2.5MG |
Prescription |
Yes |
Yes |
AA |
Approved Prior to Jan 1, 1982
|
PFIZER |
| 085372 |
001 |
ANDA |
DIPHENOXYLATE HYDROCHLORIDE AND ATROPINE SULFATE |
ATROPINE SULFATE; DIPHENOXYLATE HYDROCHLORIDE |
TABLET;ORAL |
0.025MG;2.5MG |
Prescription |
No |
No |
AA |
Approved Prior to Jan 1, 1982
|
LANNETT |
| 085762 |
001 |
ANDA |
DIPHENOXYLATE HYDROCHLORIDE AND ATROPINE SULFATE |
ATROPINE SULFATE; DIPHENOXYLATE HYDROCHLORIDE |
TABLET;ORAL |
0.025MG;2.5MG |
Discontinued |
No |
No |
AA |
Approved Prior to Jan 1, 1982
|
MYLAN |
| 086727 |
001 |
ANDA |
DIPHENOXYLATE HYDROCHLORIDE AND ATROPINE SULFATE |
ATROPINE SULFATE; DIPHENOXYLATE HYDROCHLORIDE |
TABLET;ORAL |
0.025MG;2.5MG |
Discontinued |
No |
No |
AA |
Approved Prior to Jan 1, 1982
|
ANI PHARMS |
| 210571 |
001 |
ANDA |
DIPHENOXYLATE HYDROCHLORIDE AND ATROPINE SULFATE |
ATROPINE SULFATE; DIPHENOXYLATE HYDROCHLORIDE |
TABLET;ORAL |
0.025MG;2.5MG |
Discontinued |
No |
No |
AA |
2018/08/31
|
UPSHER SMITH LABS |
| 210819 |
001 |
ANDA |
DIPHENOXYLATE HYDROCHLORIDE AND ATROPINE SULFATE |
ATROPINE SULFATE; DIPHENOXYLATE HYDROCHLORIDE |
TABLET;ORAL |
0.025MG;2.5MG |
Prescription |
No |
No |
AA |
2018/11/13
|
BAYSHORE PHARMS LLC |
| 213413 |
001 |
ANDA |
DIPHENOXYLATE HYDROCHLORIDE AND ATROPINE SULFATE |
ATROPINE SULFATE; DIPHENOXYLATE HYDROCHLORIDE |
TABLET;ORAL |
0.025MG;2.5MG |
Prescription |
No |
No |
AA |
2020/02/20
|
LEADING |
| 213335 |
001 |
ANDA |
DIPHENOXYLATE HYDROCHLORIDE AND ATROPINE SULFATE |
ATROPINE SULFATE; DIPHENOXYLATE HYDROCHLORIDE |
TABLET;ORAL |
0.025MG;2.5MG |
Prescription |
No |
No |
AA |
2020/10/06
|
SPECGX LLC |
| 207128 |
001 |
ANDA |
DIPHENOXYLATE HYDROCHLORIDE AND ATROPINE SULFATE |
ATROPINE SULFATE; DIPHENOXYLATE HYDROCHLORIDE |
TABLET;ORAL |
0.025MG;2.5MG |
Prescription |
No |
No |
AA |
2020/10/21
|
CHARTWELL RX |
| 211362 |
001 |
ANDA |
DIPHENOXYLATE HYDROCHLORIDE AND ATROPINE SULFATE |
ATROPINE SULFATE; DIPHENOXYLATE HYDROCHLORIDE |
TABLET;ORAL |
0.025MG;2.5MG |
Prescription |
No |
No |
AA |
2021/01/27
|
WINDER LABS LLC |
